Virtus ETF Advisers’s Halozyme HALO Stock Holding History

Virtus ETF Advisers’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$174K	Hold	2,690	–	–	0.08%	262
2025 Q4	$181K	Hold	2,690	–	–	0.09%	263
2025 Q3	$197K	Hold	2,690	–	–	0.11%	217
2025 Q2	$140K	Hold	2,690	–	–	0.09%	246
2025 Q1	$172K	Sell	2,690 -4,620	-63%	-$268K	0.11%	232
2024 Q4	$349K	Buy	7,310 +673	+10%	+$34.5K	0.14%	200
2024 Q3	$380K	Hold	6,637	–	–	0.18%	208
2024 Q2	$348K	Sell	6,637 -3,022	-31%	-$133K	0.17%	200
2024 Q1	$393K	Buy	9,659 +1,390	+17%	+$52.1K	0.21%	195
2023 Q4	$306K	Sell	8,269 -962	-10%	-$36.2K	0.19%	222
2023 Q3	$353K	Sell	9,231 -1,191	-11%	-$48.8K	0.21%	190
2023 Q2	$376K	Buy	10,422 +5,160	+98%	+$176K	0.22%	141
2023 Q1	$201K	Buy	5,262 +92	+2%	+$4.32K	0.11%	307
2022 Q4	$294K	Sell	5,170 -230	-4%	-$11.8K	0.15%	275
2022 Q3	$214K	Buy	5,400 +76	+1%	+$3.36K	0.09%	313
2022 Q2	$234K	Sell	5,324 -5,414	-50%	-$234K	0.09%	310
2022 Q1	$428K	Hold	10,738	–	–	0.19%	144
2021 Q4	$432K	Buy	10,738 +187	+2%	+$6.98K	0.16%	131
2021 Q3	$429K	Sell	10,551 -964	-8%	-$40.3K	0.19%	161
2021 Q2	$523K	Sell	11,515 -3,439	-23%	-$152K	0.22%	135
2021 Q1	$623K	Buy	14,954 +411	+3%	+$18.8K	0.26%	119
2020 Q4	$621K	Sell	14,543 -11,069	-43%	-$398K	0.26%	102
2020 Q3	$673K	Buy	25,612 +2,157	+9%	+$60.1K	0.35%	111
2020 Q2	$629K	Sell	23,455 -7,541	-24%	-$170K	0.3%	106
2020 Q1	$558K	Sell	30,996 -2,616	-8%	-$49.7K	0.23%	164
2019 Q4	$596K	Sell	33,612 -10,434	-24%	-$181K	0.1%	189
2019 Q3	$683K	Sell	44,046 -7,415	-14%	-$122K	0.14%	166
2019 Q2	$884K	Buy	51,461 +626	+1%	+$10.1K	0.19%	159
2019 Q1	$818K	Buy	50,835 +10,900	+27%	+$177K	1.74%	16
2018 Q4	$584K	Sell	39,935 -1,264	-3%	-$20.2K	0.1%	52
2018 Q3	$749K	Buy	41,199 +2,776	+7%	+$48.6K	0.08%	71
2018 Q2	$648K	Sell	38,423 -7,397	-16%	-$140K	0.57%	122
2018 Q1	$898K	Sell	45,820 -2,581	-5%	-$50K	0.78%	59
2017 Q4	$981K	Sell	48,401 -29,953	-38%	-$551K	1.23%	23
2017 Q3	$1.36M	Hold	78,354	–	–	0.18%	40
2017 Q2	$1M	Sell	78,354 -15,945	-17%	-$213K	0.15%	66
2017 Q1	$1.22M	Buy	94,299 +9,068	+11%	+$115K	0.22%	50
2016 Q4	$842K	Buy	85,231 +15,123	+22%	+$166K	0.25%	80
2016 Q3	$847K	Buy	70,108 +8,834	+14%	+$90.3K	0.41%	39
2016 Q2	$529K	Buy	61,274 +24,579	+67%	+$243K	0.39%	48
2016 Q1	$348K	Buy	+36,695	New	+$345K	0.48%	56

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtus ETF Advisers's HALO Position: Q1 2026 in Review

Virtus ETF Advisers held its Halozyme (HALO) position steady in Q1 2026 at 2,690 shares worth $174K. The position accounts for 0.08% of the portfolio, ranked #262.

Virtus ETF Advisers first reported a position in HALO in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.36M in Q3 2017. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Virtus ETF Advisers held 2,690 shares of Halozyme worth $174K as of Q1 2026.
Virtus ETF Advisers left its Halozyme share count unchanged in Q1 2026.
Halozyme made up 0.08% of Virtus ETF Advisers's portfolio in Q1 2026, its #262 holding.
Virtus ETF Advisers first reported a position in Halozyme in Q1 2016 and has held it in 41 quarters since.
Virtus ETF Advisers's Halozyme position peaked at $1.36M in Q3 2017.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.